Effect of biventricular pacing on heart rate variability in patients with chronic heart failure

European Journal of Heart Failure

Volumn 5, Issue 2, 2003, Pages 175-178

  Livanis, Efthimios G ^a   Flevari, Panagiota ^a   Theodorakis, George N ^a   Kolokathis, Fotis ^a   Leftheriotis, Dionyssios ^a   Kremastinos, Dimitrios Th ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Biventricular pacing; Heart failure; Heart rate variability

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; AUTONOMIC INNERVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; EXERCISE TEST; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HEART STIMULATION; HUMAN; IMPLANTATION; LONG TERM CARE; OXYGEN CONSUMPTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; QUALITY OF LIFE; WALKING;

AGED; CARDIAC PACING, ARTIFICIAL; CHRONIC DISEASE; ECHOCARDIOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MIDDLE AGED; OXYGEN CONSUMPTION; QUALITY OF LIFE; STATISTICS; STROKE VOLUME; TREATMENT OUTCOME;

EID: 0037348899     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(02)00257-X     Document Type: Article

References (20)

1. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80.
2. Stellbrink C, Breithardt OA, Franke A, et al. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol 2001;38:1957-65.
3. Barold SS. What is cardiac resynchronization therapy? Am J Med 2001;111:224-32.
4. Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart failure. Results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-Heart). Circulation 1998;98:1510-6.
5. Mäkikallio TH, Huikuri HV, Hintze U, et al. Fractal analysis and time and frequency domain measures of heart rate variability as predictors of mortality in patients with heart failure. Am J Cardiol 2001;87:178-82.
6. Gregoratos G, Cheitlin MD, Conill A, et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiar-rhythmia devices - a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 1998;31:1175-209.
7. Zugck C, Krüger C, Dürr S, et al. Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? Eur Heart J 2000;21:54-9.
8. Rector RS, Kubo SH, Cohn JN. Patients' self-assessment of their congestive heart failure, II. Content, reliability and validity of a new measure - the Minnesota Living with Heart Failure questionnaire. Heart Fail 1987;3:198-209.
9. Adamopoulos S, Kemp GJ, Tompson CH, et al. The time course of haemodynamic, autonomic and skeletal muscle abnormalities following first myocardial infarction in man. J Mol Cell Cardiol 1999;31:1913-26.
10. Lopera GA, Huikuri HV, Mäkikallio TH, et al. Is abnormal heart rate variability a specific feature of congestive heart failure? Am J Cardiol 2001;87:1211-3.
11. Hamdan MH, Zagrodzky JD, Joglar JA, et al. Biventricular pacing decreases sympathetic activity compared with right ventricular pacing in patients with reduced ejection fraction. Circulation 2000;102:1027-32.
12. Szabo BM, Van Veldhuisen DJ, Van der Veer N, Brouwer J, De Graeff PA, Crijns HJGM. Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 1997;79:978-80.
13. Fauchier L, Babuty D, Cosnay P, Fauchier JP. Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1999;33:1203-7.
14. Higgins SL, Yong P, Sheck D, et al. Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy: Ventak CHF Investigators. J Am Coll Cardiol 2000;36:824-7.
15. Zagrodzky JD, Ramaswamy K, Page RL, et al. Biventricular pacing decreases the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy. Am J Cardiol 2001;87:1208-9.
16. Huikuri HV, Mäkikallio T, Airaksinen KEJ, Mitrani JR, Castellanos A, Myerburg RJ. Measurement of heart rate variability: a clinical tool or a research toy? J Am Coll Cardiol 1999;34:1878-83.
17. Mortara A, La Rovere MT, Signorini MG, et al. Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation. Br Heart J 1994;71:422-30.
18. Auricchio A, Kloss M, Trautman SI, Rodner S, Klein H. Exercise performance following cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. Am J Cardiol 2002;89:198-203.
19. Opasich C, Pinna GD, Bobbio M, et al. Peak exercise oxygen consumption in chronic heart failure: toward efficient use in the individual patient. J Am Coll Cardiol 1998;31:766-75.
20. Isnard R, Pousset F, Trochu JN, et al. Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure. Am J Cardiol 2000;86:417-21.